261 related articles for article (PubMed ID: 29183221)
1. Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials.
Tarango C; Schulman S; Betensky M; Goldenberg NA
Expert Rev Hematol; 2018 Jan; 11(1):37-44. PubMed ID: 29183221
[TBL] [Abstract][Full Text] [Related]
2. Six Weeks Versus 3 Months of Anticoagulant Treatment for Pediatric Central Venous Catheter-related Venous Thromboembolism.
Smith R; Jones S; Newall F
J Pediatr Hematol Oncol; 2017 Oct; 39(7):518-523. PubMed ID: 28859034
[TBL] [Abstract][Full Text] [Related]
3. [Optimal duration of anticoagulation of venous thromboembolism].
Savina EN; Couturaud F
J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
[TBL] [Abstract][Full Text] [Related]
4. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
Goldenberg NA; Kittelson JM; Abshire TC; Bonaca M; Casella JF; Dale RA; Halperin JL; Hamblin F; Kessler CM; Manco-Johnson MJ; Sidonio RF; Spyropoulos AC; Steg PG; Turpie AGG; Schulman S;
JAMA; 2022 Jan; 327(2):129-137. PubMed ID: 35015038
[TBL] [Abstract][Full Text] [Related]
5. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
6. High rate of recurrent venous thromboembolism in children and adolescents with unprovoked venous thromboembolism.
Whitworth H; Clark HH; Hubbard RA; Witmer C; Leonard CE; Raffini L
J Thromb Haemost; 2023 Jan; 21(1):47-56. PubMed ID: 36695395
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center.
Leeper CM; Vissa M; Cooper JD; Malec LM; Gaines BA
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28067012
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in pediatric patients with sickle cell disease: A north American survey on experience and management approaches of pediatric hematologists.
Betensky M; Kumar R; Hankins JS; Goldenberg NA;
Thromb Res; 2022 Mar; 211():133-139. PubMed ID: 35151008
[TBL] [Abstract][Full Text] [Related]
9. Updates in pediatric venous thromboembolism.
Gillespie MA; Lyle CA; Goldenberg NA
Curr Opin Hematol; 2015 Sep; 22(5):413-9. PubMed ID: 26203734
[TBL] [Abstract][Full Text] [Related]
10. Extended therapy for primary and secondary prevention of venous thromboembolism.
Conway SE; Marcy TR
J Pharm Pract; 2010 Aug; 23(4):313-23. PubMed ID: 21507831
[TBL] [Abstract][Full Text] [Related]
11. New developments in pediatric venous thromboembolism and anticoagulation, including the target-specific oral anticoagulants.
Lyle CA; Sidonio RF; Goldenberg NA
Curr Opin Pediatr; 2015 Feb; 27(1):18-25. PubMed ID: 25564186
[TBL] [Abstract][Full Text] [Related]
12. Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.
de Jong PG; Coppens M; Middeldorp S
Br J Haematol; 2012 Aug; 158(4):433-41. PubMed ID: 22734929
[TBL] [Abstract][Full Text] [Related]
13. [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism].
Couturaud F; Kearon C
Rev Pneumol Clin; 2008 Dec; 64(6):305-15. PubMed ID: 19084210
[TBL] [Abstract][Full Text] [Related]
14. Pediatric venous thromboembolism in relation to adults.
Spentzouris G; Scriven RJ; Lee TK; Labropoulos N
J Vasc Surg; 2012 Jun; 55(6):1785-93. PubMed ID: 21944920
[TBL] [Abstract][Full Text] [Related]
15. Optimal long-term pharmacological treatment of patients with venous thromboembolism that was unprovoked or associated with weak risk factors.
Palareti G
Expert Rev Hematol; 2017 Oct; 10(10):921-931. PubMed ID: 28803491
[TBL] [Abstract][Full Text] [Related]
16. Treatment of venous thromboembolism in pediatric patients.
Witmer C; Raffini L
Blood; 2020 Jan; 135(5):335-343. PubMed ID: 31917400
[TBL] [Abstract][Full Text] [Related]
17. Increasing Incidence and Recurrence Rate of Venous Thromboembolism in Paediatric Oncology Patients in One Single Centre Over 25 Years.
Klaassen ILM; van Els AL; van de Wetering MD; van Ommen CH
Thromb Haemost; 2017 Nov; 117(11):2156-2162. PubMed ID: 28981557
[TBL] [Abstract][Full Text] [Related]
18. A Clinical Tool for the Prediction of Venous Thromboembolism in Pediatric Trauma Patients.
Connelly CR; Laird A; Barton JS; Fischer PE; Krishnaswami S; Schreiber MA; Zonies DH; Watters JM
JAMA Surg; 2016 Jan; 151(1):50-7. PubMed ID: 26422678
[TBL] [Abstract][Full Text] [Related]
19. Guidance for the prevention and treatment of cancer-associated venous thromboembolism.
Khorana AA; Carrier M; Garcia DA; Lee AY
J Thromb Thrombolysis; 2016 Jan; 41(1):81-91. PubMed ID: 26780740
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism prophylaxis in the pediatric trauma population.
Thompson AJ; McSwain SD; Webb SA; Stroud MA; Streck CJ
J Pediatr Surg; 2013 Jun; 48(6):1413-21. PubMed ID: 23845640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
